IL-15 boosts mesothelin- and CD70-CAR NK cell potency in PDAC without added benefit from dual targeting

Laura Gehrcken, Jasper Ott, Astrid Van den Eynde, Ho Wa Lau, Dana Liu, Christophe Hermans, Tias Verhezen, Stefanie Peeters, Carole Faghel, Philippe Joye, Gils Roex, Diana Campillo-Davo, Eva Lion, Filipe Elvas, Senada Koljenovic, Jorrit De Waele, Vera Hartman, Geert Roeyen, Hans Prenen, Filip Lardon, Christophe Deben, Evelien Smits, Jonas Van Audenaerde

Open source

DOI
10.1016/j.omton.2026.201316
Published
2026-09
Container
Molecular Therapy Oncology
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.omton.2026.201316,
  title = {IL-15 boosts mesothelin- and CD70-CAR NK cell potency in PDAC without added benefit from dual targeting},
  author = {Laura Gehrcken and Jasper Ott and Astrid Van den Eynde and Ho Wa Lau and Dana Liu and Christophe Hermans and Tias Verhezen and Stefanie Peeters and Carole Faghel and Philippe Joye and Gils Roex and Diana Campillo-Davo and Eva Lion and Filipe Elvas and Senada Koljenovic and Jorrit De Waele and Vera Hartman and Geert Roeyen and Hans Prenen and Filip Lardon and Christophe Deben and Evelien Smits and Jonas Van Audenaerde},
  year = {2026},
  journal = {Molecular Therapy Oncology},
  doi = {10.1016/j.omton.2026.201316},
  url = {https://doi.org/10.1016/j.omton.2026.201316}
}

RIS

TY  - JOUR
TI  - IL-15 boosts mesothelin- and CD70-CAR NK cell potency in PDAC without added benefit from dual targeting
AU  - Laura Gehrcken
AU  - Jasper Ott
AU  - Astrid Van den Eynde
AU  - Ho Wa Lau
AU  - Dana Liu
AU  - Christophe Hermans
AU  - Tias Verhezen
AU  - Stefanie Peeters
AU  - Carole Faghel
AU  - Philippe Joye
AU  - Gils Roex
AU  - Diana Campillo-Davo
AU  - Eva Lion
AU  - Filipe Elvas
AU  - Senada Koljenovic
AU  - Jorrit De Waele
AU  - Vera Hartman
AU  - Geert Roeyen
AU  - Hans Prenen
AU  - Filip Lardon
AU  - Christophe Deben
AU  - Evelien Smits
AU  - Jonas Van Audenaerde
PY  - 2026
JO  - Molecular Therapy Oncology
DO  - 10.1016/j.omton.2026.201316
UR  - https://doi.org/10.1016/j.omton.2026.201316
ER  - 

APA

Gehrcken, L., Ott, J., Eynde, A. V. D., Lau, H. W., Liu, D., Hermans, C., Verhezen, T., Peeters, S., Faghel, C., Joye, P., Roex, G., Campillo-Davo, D., Lion, E., Elvas, F., Koljenovic, S., Waele, J. D., Hartman, V., Roeyen, G., Prenen, H., Lardon, F., Deben, C., Smits, E., & Audenaerde, J. V. (2026). IL-15 boosts mesothelin- and CD70-CAR NK cell potency in PDAC without added benefit from dual targeting. Molecular Therapy Oncology. https://doi.org/10.1016/j.omton.2026.201316

Source records